Who Can Benefit from the Oncotype DX Colon Cancer Test?

What makes a good candidate for the Oncotype DX colon cancer test?

stage ii colon cancer treatmentAre you wondering if you’re a good candidate for the Oncotype DX test for colon cancer? Looking for some answers? Dr. Mark Kozloff has got them in this video. Not everyone can benefit from this test, but those that do can have some surprising results. Check out the video to learn more about the Oncotype DX test for colon cancer.

To learn more about the Oncotype DX test watch “Oncotype DX Colon Cancer Treatment Decisions” with Dr. Mark Kozloff.

Video Transcripts

Mark F. Kozloff, MD: When I sit down with patients and we decide about doing Oncotype DX assay in colorectal cancer, there are some patients who I would not order it on. I have some patients who would basically tell me that they won’t take chemotherapy for a 2% benefit or for 6% benefit or even for a 20% benefit and those patients just won’t help them with their decision making but I have other patients that more likely their cancer is to come back, the more likely they are to take an adjuvant treatment, that can help them immensely with knowing what their personal risk of the cancer coming back is and what benefits as well as risks they may have going on their treatment. So, I would say most patients with colon cancer want to know this, but there is a few that it won’t help.

Mark Kozloff
Dr. Mark Kozloff is board certified in Internal Medicine. He earned his degree in medicine from the University of Michigan Medical School and completed his residency at Michael Reese Hospital in Chicago. Dr. Kozloff works on a multidisciplinary team of experts in the Center for Gastrointestinal Oncology where he specializes in the treatment of colorectal malignancies.

This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.

© 2022 Cancer Answers LLC